Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice

Pharmacology

Volumn 95, Issue 3-4, 2015, Pages 173-180

  Zhang, Nan ^a   Lu, Yunxia ^a,b   Shen, Xinru ^a   Bao, Yingying ^a   Cheng, Jingjing ^b   Chen, Li ^b   Li, Bao ^a   Zhang, Qiu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Department of Biochemistry and Molecular Biology ^*  (China)

Author keywords

Apoptosis; Endoplasmic reticulum stress; Fenofibrate; High calorie and high cholesterol diet; Liver; Nonalcoholic fatty liver disease

Indexed keywords

FENOFIBRATE; INSULIN; LIPID; LIVER PROTECTIVE AGENT; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN IRE1; TRIACYLGLYCEROL; X BOX BINDING PROTEIN 1; ANTILIPEMIC AGENT; CHOLESTEROL; DDIT3 PROTEIN, MOUSE; ERN1 PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MOLECULAR CHAPERONE GRP78; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN SERINE THREONINE KINASE; RIBONUCLEASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; FEEDING; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIVER CELL; LIVER HISTOLOGY; LIVER PROTECTION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PATHOLOGY;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CHOLESTEROL; ENDOPLASMIC RETICULUM STRESS; ENDORIBONUCLEASES; FENOFIBRATE; HEAT-SHOCK PROTEINS; HYPOLIPIDEMIC AGENTS; INSULIN RESISTANCE; LIVER; MALE; MAP KINASE KINASE 4; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PPAR ALPHA; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTOR CHOP; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928111720     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000380952     Document Type: Article

References (24)

1. Tiniakos DG, Vos MB, Brunt EM: Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010; 5: 145-171.
2. Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM: Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988-1994. Am J Epidemiol 2013; 178: 38-45.
3. Puri P, Mirshahi F, Cheung O, Natarajan R, Maher JW, Kellum JM, Sanyal AJ: Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 2008; 134: 568-576.
4. Czaja MJ: JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab 2010; 21: 707-713.
5. Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ: JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 2006; 43: 163-172.
6. Kostapanos MS, Kei A, Elisaf MS: Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease. World J Hepatol 2013; 5: 470-478.
7. Harano Y, Yasui K, Toyama T, Nakajima T, Mitsuyoshi H, Mimani M, Hirasawa T, Itoh Y, Okanoue T: Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. Liver Int 2006; 26: 613-620.
8. Rahman SM, Qadri I, Janssen RC, Friedman JE: Fenofibrate and PBA prevent fatty acidinduced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis. J Lipid Res 2009; 50: 2193-2202.
9. Chan SM, Sun RQ, Zeng XY, Choong ZH, Wang H, Watt MJ, Ye JM: Activation of PPAR ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes 2013; 62: 2095-2105.
10. Yan F, Wang Q, Xu C, Cao M, Zhou X, Wang T, Yu C, Jing F, Chen W, Gao L, Zhao J: Peroxisome proliferator-activated receptor activation induces hepatic steatosis, suggesting an adverse effect. PLoS One 2014, 9:e99245.
11. Lu Y, Qian L, Zhang Q, Chen B, Gui L, Huang D, Chen G, Chen L: Palmitate induces apoptosis in mouse aortic endothelial cells and endothelial dysfunction in mice fed high-calorie and high-cholesterol diets. Life Sci 2013; 92: 1165-1173.
12. Carr TP, Andresen CJ, Rudel LL: Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 1993; 26: 39-42.
13. Mu YP, Ogawa T, Kawada N: Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-choline-deficient diet. Lab Invest 2010; 90: 245-256.
14. Cong WN, Tao RY, Tian JY, Liu GT, Ye F: The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Life Sci 2008; 82: 983-990.
15. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D: Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000; 287: 664-666.
16. Cohen JC, Horton JD, Hobbs HH: Human fatty liver disease: old questions and new insights. Science 2011; 332: 1519-1523.
17. Tilg H, Moschen AR: Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010; 52: 1836-1846.
18. Moschen AR, Molnar C, Geiger S, Graziadei I, Ebenbichler CF, Weiss H, Kaser S, Kaser A, Tilg H: Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumor necrosis factor alpha expression. Gut 2010; 59: 1259-1264.
19. Mohamed DI, Elmelegy AA, El-Aziz LF, Abdel Kawy HS, El-Samad AA, El-Kharashi OA: Fenofibrate A peroxisome proliferator activated receptor-agonist treatment ameliorates concanavalin A-induced hepatitis in rats. Eur J Pharmacol 2013; 721: 35-42.
20. Kersten S: Regulation of nutrient metabolism and inflammation. Results Probl Cell Differ 2010; 52: 13-25.
21. Tajiri S, Yano S, Morioka M, Kuratsu J, Mori M, Gotoh T: CHOP is involved in neuronal apoptosis induced by neurotrophic factor deprivation. FEBS Lett 2006; 580: 3462-3468.
22. Zhang K, Wang S, Malhotra J, Hassler JR, Back SH, Wang G, Chang L, Xu W, Miao H, Leonardi R, Chen YE, Jackowski S, Kaufman RJ: The unfolded protein response transducer IRE1 prevents ER stress-induced hepatic steatosis. EMBO J 2011; 30: 1357-1375.
23. Lee AH, Scapa EF, Cohen DE, Glimcher LH: Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 2008; 320: 1492-1496.
24. Hotamisligil GS: Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010; 140: 900-917.